Choukroun G, et al.. Incidence and management of anemia in renal transplantation: an observational-French study. Nephrol Ther 2008; 4:575–583.

• PubMed
Choukroun G, . Incidence and management of anemia in renal transplantation: an observational-French study. Nephrol Ther 2008; 4:575–583.)| false
• Search Google Scholar
• Export Citation

Molnar MZ, et al.. Prevalence and management of anaemia in renal transplant recipients: data from ten European centres. Nephron Clin Pract 2011; 117:c127–c134.

• PubMed
Molnar MZ, . Prevalence and management of anaemia in renal transplant recipients: data from ten European centres. Nephron Clin Pract 2011; 117:c127–c134.)| false
• Search Google Scholar
• Export Citation

Vanrenterghem Y, et al.. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003; 3:835–845.

• PubMed
Vanrenterghem Y, . Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003; 3:835–845.)| false
• Search Google Scholar
• Export Citation

Awan AA, et al.. Trends in the causes of death among kidney transplant recipients in the United States (1996–2014). Am J Nephrol 2018; 48:472–481.

• PubMed
Awan AA, . Trends in the causes of death among kidney transplant recipients in the United States (1996–2014). Am J Nephrol 2018; 48:472–481.)| false
• Search Google Scholar
• Export Citation

Imoagene-Oyedeji AE, et al.. Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol 2006; 17:3240–3247.

• PubMed
Imoagene-Oyedeji AE, . Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol 2006; 17:3240–3247.)| false
• Search Google Scholar
• Export Citation

Kamar N, Rostaing L. Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil. Transplantation 2008; 85:1120–1124.

• PubMed
Kamar N, Rostaing L. Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil. Transplantation 2008; 85:1120–1124.)| false
• Search Google Scholar
• Export Citation

Molnar MZ, et al.. Anemia is associated with mortality in kidney-transplanted patients: a prospective cohort study. Am J Transplant 2007; 7:818–824.

• PubMed
Molnar MZ, . Anemia is associated with mortality in kidney-transplanted patients: a prospective cohort study. Am J Transplant 2007; 7:818–824.)| false
• Search Google Scholar
• Export Citation

Winkelmayer WC, et al.. A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant 2006; 21:3559–3566.

• PubMed
Winkelmayer WC, . A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant 2006; 21:3559–3566.)| false
• Search Google Scholar
• Export Citation

Winkelmayer WC, et al.. Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant 2004; 4:2075–2081.

• PubMed
Winkelmayer WC, . Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant 2004; 4:2075–2081.)| false
• Search Google Scholar
• Export Citation

Kawada N, et al.. Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients. Clin Exp Nephrol 2009; 13:355–360.

• PubMed
Kawada N, . Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients. Clin Exp Nephrol 2009; 13:355–360.)| false
• Search Google Scholar
• Export Citation

Mix TC, et al.. Anemia: a continuing problem following kidney transplantation. Am J Transplant 2003; 3:1426–1433.

• PubMed
Mix TC, . Anemia: a continuing problem following kidney transplantation. Am J Transplant 2003; 3:1426–1433.)| false
• Search Google Scholar
• Export Citation

Kamar N, et al.. Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis. Clin Transplant 2012; 26:461–469.

• PubMed
Kamar N, . Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis. Clin Transplant 2012; 26:461–469.)| false
• Search Google Scholar
• Export Citation

Cassis P, et al.. Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. Kidney Int 2012; 81:903–918.

• PubMed
Cassis P, . Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. Kidney Int 2012; 81:903–918.)| false
• Search Google Scholar
• Export Citation

Diskin CJ, et al.. Beyond anemia: the clinical impact of the physiologic effects of erythropoietin. Semin Dial 2008; 21:447–454.

• PubMed
Diskin CJ, . Beyond anemia: the clinical impact of the physiologic effects of erythropoietin. Semin Dial 2008; 21:447–454.)| false
• Search Google Scholar
• Export Citation

Purroy C, et al.. Erythropoietin receptor-mediated molecular crosstalk promotes T cell immunoregulation and transplant survival. J Am Soc Nephrol 2017; 28:2377–2392.

• PubMed
Purroy C, . Erythropoietin receptor-mediated molecular crosstalk promotes T cell immunoregulation and transplant survival. J Am Soc Nephrol 2017; 28:2377–2392.)| false
• Search Google Scholar
• Export Citation

Drueke TB, et al.. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355:2071–2084.

• PubMed
Drueke TB, . Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355:2071–2084.)| false
• Search Google Scholar
• Export Citation

Singh AK, et al.. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355:2085–2098.

• PubMed
Singh AK, . Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355:2085–2098.)| false
• Search Google Scholar
• Export Citation

Pfeffer MA, et al.. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361:2019–2032.

• PubMed
Pfeffer MA, . A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361:2019–2032.)| false
• Search Google Scholar
• Export Citation

Besarab A, et al.. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339:584–590.

• PubMed
Besarab A, . The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339:584–590.)| false
• Search Google Scholar
• Export Citation

KDOQI, National Kidney Foundation. IV. Clinical practice recommendations for anemia in chronic kidney disease in transplant recipients. Am J Kidney Dis 2006; 47:S109–S116.

• PubMed
KDOQI, National Kidney Foundation. IV. Clinical practice recommendations for anemia in chronic kidney disease in transplant recipients. Am J Kidney Dis 2006; 47:S109–S116.)| false
• Search Google Scholar
• Export Citation

Kasiske BL, et al.. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2010; 77:299–311.

• PubMed
Kasiske BL, . KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2010; 77:299–311.)| false
• Search Google Scholar
• Export Citation

Heinze G, et al.. Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study. BMJ 2009; 339:b4018.

• PubMed
Heinze G, . Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study. BMJ 2009; 339:b4018.)| false
• Search Google Scholar
• Export Citation

Choukroun G, et al.. Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol 2012; 23:360–368.

• PubMed
Choukroun G, . Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol 2012; 23:360–368.)| false
• Search Google Scholar
• Export Citation

Tsujita M, et al.. The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial [published online ahead of print Dec 17, 2017]. Nephrol Dial Transplant doi: 10.1093/ndt/gfy365.

• PubMed
Tsujita M, . The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial [published online ahead of print Dec 17, 2017]. Nephrol Dial Transplant doi: 10.1093/ndt/gfy365.)| false
• Search Google Scholar
• Export Citation